JNJ Total Debt
Short-term plus long-term borrowings at each quarter end, before any offset for cash.
Total Debt
Latest: $49.04B (2026Q2)
| Period | Value |
|---|---|
| 2020Q3 | $37.76B |
| 2020Q4 | $35.27B |
| 2021Q1 | $33.61B |
| 2021Q2 | $33.48B |
| 2021Q3 | $33.93B |
| 2021Q4 | $33.75B |
| 2022Q1 | $33.15B |
| 2022Q2 | $32.60B |
| 2022Q3 | $32.03B |
| 2022Q4 | $39.64B |
| 2023Q1 | $52.91B |
| 2023Q2 | $45.60B |
| 2023Q3 | $29.92B |
| 2023Q4 | $29.33B |
| 2024Q1 | $33.63B |
| 2024Q2 | $41.49B |
| 2024Q3 | $35.75B |
| 2024Q4 | $36.63B |
| 2025Q1 | $52.25B |
| 2025Q2 | $50.76B |
| 2025Q3 | $45.80B |
| 2025Q4 | $47.93B |
| 2026Q1 | $54.99B |
| 2026Q2 | $49.04B |
Other JNJ Charts
More quarter-by-quarter fundamentals for Johnson & Johnson
1 / 10
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Total Assets
Rule of 40
Healthcare Comparison
1 / 3
Latest Total Debt: $49.04B (2026Q2); -3.4% YoY; +6.9% CAGR since 2011Q1 (15.25y).
Across the 62 quarters from 2011Q1 to 2026Q2, Total Debt ranged from $14.98B in 2013Q2 to $54.99B in 2026Q1.
Chart and table show the latest 24 of 62 quarters.